Professional Marketing briefs

Share this article:
Sanofi-Aventis settled a lawsuit accusing the company of underpaying 4,000 female reps in the US, and will pay $15.4 million as part of the settlement. Affected reps will see an increase in their base pay as a result of the settlement. Meanwhile a Novartis rep prevailed in her suit against the company, which she accused of slashing her territory and eliminating her position in retaliation for having taken maternity leave.

Valeant Pharmaceuticals entered into an agreement with Spear Pharmaceuticals for rights to commercialize Refissa, a prescription wrinkle and sun damage cream. Valeant will pay $12 million and the companies will share netprofit.

Arena Pharmaceuticals is looking for a commercial partner for its weight loss drug lorcaserin, pending approval, but will launch without if need be, the company told Reuters. The company is competing with Vivus Inc and Orexigen Therapeutics for first-to-market status.
Share this article:
close

Next Article in Features

Email Newsletters

More in Features

Antidote: On Cystic Fibrosis treatments

Antidote: On Cystic Fibrosis treatments

Recent treatments in CF, including the inhaled antibiotic Tobramycin, have increased lifespan well into adulthood.

The $3 generic and the $1,000 pill: pharma outsiders just don't get it

The $3 generic and the $1,000 pill: pharma ...

What do you call the people who treat medical breakthroughs as if they were bank heists? Malicious? Uninformed? Not with it?

Leadership Exchange Uncut : The Agency-Client Relationship

Leadership Exchange Uncut : The Agency-Client Relationship

Click the above link to access MM&M's first Leadership Exchange Uncut e-book, "The Agency-Client Relationship"